Article Details
Retrieved on: 2023-01-04 03:10:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
CM-101 is a first-in-class monoclonal antibody designed to target the CCL24 protein, a key regulator in fibrotic-inflammatory pathways. The candidate ...
Article found on: www.pharmalive.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here